Markus Jerling is born 1955 and Chief Medical Officer (CMO) at Kancera AB. Dr. Jerling has a PhD in clinical pharmacology and more than twenty-five years of experience of international drug development and has held various management positions in both Swedish and US companies. In addition to his experience of drug development in all clinical phases, he has fifteen years of experience from academic research and as a practising physician.
Back